Drugs / Inactivated Bacteroides fragilis
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT07309315 | Mar → Dec 2026 expected | chemotherapy-induced toxicity | Shenzhen Hospital of Southern Medical University | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Inactivated Bacteroides fragilis | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07309315 ↗ |
| Known as | SK10 | “This study intends to conduct a randomized controlled trial to determine the efficacy and mechanism of action of inactivated Bacteroides fragilis (SK10) in the prevention of...” NCT07309315 ↗ |